UpHealth (UPHL) Competitors $0.0004 +0.00 (+33.33%) (As of 12/20/2024 04:19 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsTrends UPHL vs. BTTX, ACONW, AONC, DHACW, CORBF, LFMDP, OTRKP, PIIIW, TALKW, and TOIIWShould you be buying UpHealth stock or one of its competitors? The main competitors of UpHealth include Better Therapeutics (BTTX), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Global Cord Blood (CORBF), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), and Oncology Institute (TOIIW). These companies are all part of the "healthcare" industry. UpHealth vs. Better Therapeutics Aclarion American Oncology Network Digital Health Acquisition Global Cord Blood LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute UpHealth (NYSE:UPHL) and Better Therapeutics (NASDAQ:BTTX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk. Which has more risk & volatility, UPHL or BTTX? UpHealth has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500. Comparatively, Better Therapeutics has a beta of 1.9, suggesting that its share price is 90% more volatile than the S&P 500. Does the media refer more to UPHL or BTTX? In the previous week, UpHealth's average media sentiment score of 0.00 equaled Better Therapeutics'average media sentiment score. Company Overall Sentiment UpHealth Neutral Better Therapeutics Neutral Which has stronger earnings and valuation, UPHL or BTTX? Better Therapeutics has lower revenue, but higher earnings than UpHealth. UpHealth is trading at a lower price-to-earnings ratio than Better Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUpHealth$130M0.00-$56.42M-$1.350.00Better TherapeuticsN/AN/A-$39.76M-$1.150.00 Is UPHL or BTTX more profitable? UpHealth's return on equity of 34.37% beat Better Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets UpHealthN/A 34.37% 9.54% Better Therapeutics N/A N/A N/A Do insiders and institutionals believe in UPHL or BTTX? 56.1% of UpHealth shares are held by institutional investors. Comparatively, 34.0% of Better Therapeutics shares are held by institutional investors. 34.2% of UpHealth shares are held by company insiders. Comparatively, 51.4% of Better Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community favor UPHL or BTTX? Better Therapeutics received 5 more outperform votes than UpHealth when rated by MarketBeat users. CompanyUnderperformOutperformUpHealthN/AN/ABetter TherapeuticsOutperform Votes541.67% Underperform Votes758.33% SummaryBetter Therapeutics beats UpHealth on 6 of the 10 factors compared between the two stocks. Ad Investors AlleyCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69% dividend from Tesla… Which could put up to $7,013 in your pocket every month…Click here to discover the new #1 way to invest in Tesla Get UpHealth News Delivered to You Automatically Sign up to receive the latest news and ratings for UPHL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPHL vs. The Competition Export to ExcelMetricUpHealthHealth services IndustryMedical SectorNYSE ExchangeMarket Cap$8,000.00$867.07M$5.14B$19.19BDividend YieldN/A1.90%5.09%3.61%P/E Ratio0.0032.2089.8241.30Price / Sales0.003.751,116.2117.58Price / CashN/A25.1442.8921.28Price / Book0.002.924.785.32Net Income-$56.42M-$5.79M$120.23M$989.88M7 Day PerformanceN/A-4.93%-1.92%-3.54%1 Month PerformanceN/A-4.89%11.49%-3.68%1 Year PerformanceN/A226.77%30.57%12.14% UpHealth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPHLUpHealthN/A$0.00+33.3%N/A-99.8%$8,000.00$130M0.001,750Gap UpBTTXBetter TherapeuticsN/A$0.00flatN/A-99.9%$5,000.00N/A0.0040ACONWAclarionN/A$0.04flatN/A-36.1%$0.00$49,289.000.007Positive NewsAONCAmerican Oncology NetworkN/A$4.68+2.7%N/A-22.5%$0.00$1.34B0.001,520News CoverageDHACWDigital Health AcquisitionN/A$0.06flatN/AN/A$0.00N/A0.00N/ACORBFGlobal Cord BloodN/A$1.26flatN/A+15.4%$0.00$196.12M0.001,202High Trading VolumeLFMDPLifeMDN/A$22.16-1.6%N/A+17.1%$0.00$193.06M0.00230OTRKPOntrakN/A$0.28-3.5%N/A-57.6%$0.00$10.84M0.00250Gap DownPIIIWP3 Health PartnersN/A$0.01-1.2%N/AN/A$0.00$1.48B0.00500Positive NewsTALKWTalkspaceN/A$0.13-2.2%N/A+7.1%$0.00$181.29M0.00500Gap DownTOIIWOncology InstituteN/A$0.01-1.0%N/A-95.0%$0.00$378.93M0.00660Positive News Related Companies and Tools Related Companies BTTX Alternatives ACONW Alternatives AONC Alternatives DHACW Alternatives CORBF Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives TOIIW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:UPHL) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding UpHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share UpHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.